Total Reports
25
Below-median volume
Breed profile · FDA CVM July 2026 extract
Adverse-event filings for Crossbred Caprine/goat (Goat) in the FDA Center for Veterinary Medicine openFDA extract. Browse goat breeds, reactions, and outcomes below.
By recorded gender -- every report on file for Crossbred Caprine/goat, no filtering.
Data updated September 2026
The verdict
According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Crossbred Caprine/goat ranks #341 of 510 by total reports (25). Death-coded-share rank requires at least 50 reports. National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).
Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.
Release-over-release change
Between the reconstructed pre-2025-Q4 openFDA partition and the 2026-07-27 openFDA export snapshot, Crossbred Caprine/goat's report count moved from 25 to 25: 0 the same number of (0.0%).
The comparison is limited to reported-event counts across two snapshots: it is not evidence of a real-world risk or safety change.
Subscribe to Crossbred Caprine/goat changesTotal Reports
25
Below-median volume
Deaths Reported
11
of 25 reports
Death-coded share of reports
44.0%
44.0% death-coded
Avg Age at Report
1.9 yr
21.7 kg avg weight
44.0% of 25 crossbred caprine/goat reports involved a death outcome.
Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
| Year | Reports | Trend |
|---|---|---|
| 2010 | 6 | |
| 2011 | 1 | |
| 2012 | 1 | |
| 2014 | 3 | |
| 2016 | 1 | |
| 2017 | 5 | |
| 2020 | 2 | |
| 2021 | 1 | |
| 2023 | 3 | |
| 2025 | 2 | |
Signature read: Crossbred Caprine/goat's 44.0% death-coded share is in the upper third of the ≥50-report cohort (median 4.8%). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Crossbred Caprine/goat sits at #342 of 510 by report volume among all breeds and #5 of 9 among goat breeds, with 25 reports and 11 (44.0%) death-coded. Mean age at report: 1.9 years, average weight 21.7 kg (47.8 lbs).
Top reported signs: Death (8), Diarrhoea (4), Skin and tissue infection NOS (4). Most-referenced drug: Moxidectin (4 reports), followed by Ivermectin 10 Mg/Ml Solution For Injection (3) and Fenbendazol Suspension (3).
Outcome coding on 26 status-recorded reports is dominated by Died (42.3%). Annual submissions ranged 1-2,025 across 10 years on file.
Showing 6 of 8 goat breeds in our dataset, ranked by closest report volume.
Sparse-volume peer sets for Crossbred Caprine/goat drawn from openFDA outside the Goat family so the neighborhoods are not species containment (the similar-volume list above stays within species).
Nearest other-species breeds by reported average weight (21.7 kg here).
What to do with this goat
Filing a report never proves the drug caused the reaction -- and a breed as widely owned as Crossbred Caprine/goat will always generate more raw reports.
Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how the death-coded share and rankings are computed, or read breed-specific reporting patterns and FDA CVM reporting.
Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025
Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →